Avobenzone for Broad-Spectrum UVA Protection Sun Damage Prevention and Skin Photoaging Defense

1. Description

Avobenzone is a benzophenone derivative, chemically known as butyl methoxybenzophenone, and belongs to the class of organic UVA filters. It appears as a white to off-white crystalline powder, is oil-soluble, and has the molecular formula C₂₀H₂₂O₃ and a molecular weight of approximately 310.39 Da. This compound primarily exists in the enol form, with its configuration stabilized by intramolecular hydrogen bonds, thereby conferring its UVA-absorbing activity. Avobenzone has a UV absorption peak at 357 nm and covers both the UVA I (340–400 nm) and UVA II (320–340 nm) bands; it is one of the few UVA filters approved by the FDA. It must be stored in a cool, dry place, protected from light and kept tightly sealed. Due to its light sensitivity, it undergoes enol-ketone tautomerism under UV irradiation, leading to degradation and loss of protective efficacy.

2. Application

(1) Sunscreen Product Development: As a key UVA filter, it is widely incorporated into sunscreens, sun lotions, sun sticks, and other products, and is used in combination with UVB filters to provide broad-spectrum protection. Common trade names in cosmetics include Parsol 1789, Eusolex 9020, and Escalol 517.

(2) Photostability Studies: Used to investigate the stabilizing effects of photostabilizers (such as octocrylene and diethylamino hydroxybenzoyl hexyl benzoate) on avobenzone, as well as the role of nanocarriers (such as nanostructured lipid carriers) in improving its photostability and skin retention.

(3) Antioxidant Formulation Studies: To investigate the role of antioxidants such as Coenzyme Q10, Vitamin C, Vitamin E, and resveratrol in enhancing the photostability of avobenzone while simultaneously reducing the levels of reactive oxygen species generated by its photodegradation.

(4) Development of New Derivatives: Used as lead compounds for structural modification studies to develop avobenzone derivatives with enhanced photostability and reduced skin permeability, such as pyrimidine derivatives and derivatives hybridized with resveratrol.

(5) Clinical Sunscreen Applications: Used to prevent sun-induced skin damage, premature skin aging, and skin cancer, in conjunction with other sun protection measures.

3. Main Efficacy

(1) Full-spectrum UVA absorption: Avobenzone exists in the enol form and stabilizes its conformation through intramolecular hydrogen bonding. It absorbs the entire UVA spectrum ranging from 320 to 400 nm, with a maximum absorption peak at 357 nm. It is one of the few organic filters currently approved by the FDA that provides UVA I protection.

(2) Limited photostability: Under UV irradiation, the enol form of avobenzone undergoes photoisomerization to the ketone form, which is subsequently degraded via a Norrish-type I cleavage reaction, leading to a loss of UVA protection. It must be formulated with photostabilizers (such as octocrylene) or antioxidants (such as coenzyme Q10) to enhance stability.

(3) Synergistic sunscreen enhancement and antioxidant effects: When formulated with antioxidants (such as resveratrol, vitamin C, or vitamin E), these antioxidants can quench the reactive oxygen species generated during the photodegradation of avobenzone, while simultaneously enhancing the formulation’s overall photoprotective efficacy.

(4) Broadening the Spectral Coverage of New Derivatives: Through structural modifications (such as pyrimidine derivatives or hybridization with resveratrol), new filters can be developed that offer both UVB and UVA II protection, exhibit enhanced photostability, and are free of phototoxicity and photoreactivity.

(5) Performance improvements of nanocarriers: Encapsulation in nanostructured lipid carriers can improve avobenzone’s photostability, enhance its retention on the skin surface, and reduce skin penetration, thereby increasing the safety and efficacy of sunscreen products.